Quoin Pharmaceuticals (QNRX)

• Market cap: $8.98M
• 1 day: 8.68%
• 5 days: 90.88%
• 1 month: 95.27%
• 3 months: 73.72%
• 6 months: 160.14%
• Year to date: -35.02%
• 1 year: -13.44%
• 5 years: -99.97%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3